Influence of probenecid on serum levels and urinary excretion of cinoxacin
- PMID: 464575
- PMCID: PMC352685
- DOI: 10.1128/AAC.15.3.465
Influence of probenecid on serum levels and urinary excretion of cinoxacin
Abstract
Serum levels and urinary excretion of cinoxacin were examined in healthy individuals after a two-step intravenous infusion in the presence and absence of probenecid. After dosing cinoxacin alone, steady-state serum levels were approached in 1 h and were maintained for an additional 2 h with a reduced infusion rate. After probenecid pretreatment, serum levels of cinoxacin continued to increase during 3 h of infusion, reaching levels approximately double those obtained with cinoxacin alone. The mean elimination half-life of cinoxacin from serum was increased from 1.3 to 3.5 h in the presence of probenecid, and renal clearance was significantly reduced, with 46% of dosed drug appearing in 7-h urines of probenecid-treated subjects compared with 68% in subjects receiving cinoxacin alone. Probenecid had no apparent influence on cinoxacin distribution in the body but caused a significant decrease in the rate of cinoxacin extrarenal elimination, possibly due to competition for a common metabolic pathway.
Similar articles
-
Cinoxacin: pharmacokinetics and the effect of probenecid.J Clin Pharmacol. 1978 Oct;18(10):491-9. doi: 10.1002/j.1552-4604.1978.tb01577.x. J Clin Pharmacol. 1978. PMID: 711932
-
Cinoxacin in female mongrel dogs: effect of urine pH on urinary drug excretion and correlation of in vitro characteristics of oral dosage forms with bioavailability.J Pharm Sci. 1979 Feb;68(2):227-32. doi: 10.1002/jps.2600680227. J Pharm Sci. 1979. PMID: 34019 No abstract available.
-
Pharmacology of cinoxacin in humans.Antimicrob Agents Chemother. 1979 Feb;15(2):165-70. doi: 10.1128/AAC.15.2.165. Antimicrob Agents Chemother. 1979. PMID: 426511 Free PMC article.
-
Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.Pharmacotherapy. 1982 Sep-Oct;2(5):266-72. doi: 10.1002/j.1875-9114.1982.tb03195.x. Pharmacotherapy. 1982. PMID: 6763208 Review.
-
Cinoxacin (Cinobac, Eli Lilly & Co.).Drug Intell Clin Pharm. 1982 Dec;16(12):916-21. doi: 10.1177/106002808201601203. Drug Intell Clin Pharm. 1982. PMID: 6759090 Review.
Cited by
-
The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.Br J Clin Pharmacol. 1981 Apr;11(4):353-9. doi: 10.1111/j.1365-2125.1981.tb01132.x. Br J Clin Pharmacol. 1981. PMID: 7259928 Free PMC article.
-
Renal handling of fleroxacin in rabbits, dogs, and humans.Antimicrob Agents Chemother. 1990 Jan;34(1):58-64. doi: 10.1128/AAC.34.1.58. Antimicrob Agents Chemother. 1990. PMID: 2109576 Free PMC article.
-
Pharmacokinetics: metabolism and renal excretion of quinolones in man.Pharm Weekbl Sci. 1986 Feb 21;8(1):29-34. doi: 10.1007/BF01975476. Pharm Weekbl Sci. 1986. PMID: 3960691
-
Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):251-9. doi: 10.1007/BF03188755. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6653617
-
Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.Antimicrob Agents Chemother. 1980 May;17(5):847-55. doi: 10.1128/AAC.17.5.847. Antimicrob Agents Chemother. 1980. PMID: 7396472 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources